| Trevin Richard Wallin, MD | |
|
2255 N. 1700 W., #100, Layton, UT 84041-1140 | |
| (801) 773-0690 | |
| (801) 773-0697 |
| Full Name | Trevin Richard Wallin |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 21 Years |
| Location | 2255 N. 1700 W., Layton, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396885422 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4301083517 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Davis Hospital And Medical Center | Layton, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Insight Eye Specialists Pc | 5890785026 | 3 |
News Archive
Prostate cancer is the second most common type of cancer in men and is predicted to result in an estimated 220,00 cases in the United States in 2015. In recent years, an emphasis has been placed on chemoprevention - the use of agents to prevent the development or progression of prostate cancer.
The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene.
Women & Infants Hospital of Rhode Island, a Care New England hospital, announced today that it has been recognized as a 2014 Top Performer on Key Quality Measures by The Joint Commission, the leading accreditor of health care organizations in the U.S.
Dietary cadmium, a toxic metal widely dispersed in the environment and found in many farm fertilizers, may lead to an increased risk of breast cancer, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.
Stage III colon cancer patients in the general population who receive adjuvant treatment for the disease have an improved rate of survival when oxaliplatin is added to 5-fluorouracil (5FU), according to a study published Jan. 20 in the Journal of the National Cancer Institute.
› Verified 6 days ago
| Entity Name | Insight Eye Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346232196 PECOS PAC ID: 5890785026 Enrollment ID: O20040518000482 |
News Archive
Prostate cancer is the second most common type of cancer in men and is predicted to result in an estimated 220,00 cases in the United States in 2015. In recent years, an emphasis has been placed on chemoprevention - the use of agents to prevent the development or progression of prostate cancer.
The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene.
Women & Infants Hospital of Rhode Island, a Care New England hospital, announced today that it has been recognized as a 2014 Top Performer on Key Quality Measures by The Joint Commission, the leading accreditor of health care organizations in the U.S.
Dietary cadmium, a toxic metal widely dispersed in the environment and found in many farm fertilizers, may lead to an increased risk of breast cancer, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.
Stage III colon cancer patients in the general population who receive adjuvant treatment for the disease have an improved rate of survival when oxaliplatin is added to 5-fluorouracil (5FU), according to a study published Jan. 20 in the Journal of the National Cancer Institute.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Trevin Richard Wallin, MD 2255 N. 1700 W., #100, Layton, UT 84041-1140 Ph: (801) 773-0690 | Trevin Richard Wallin, MD 2255 N. 1700 W., #100, Layton, UT 84041-1140 Ph: (801) 773-0690 |
News Archive
Prostate cancer is the second most common type of cancer in men and is predicted to result in an estimated 220,00 cases in the United States in 2015. In recent years, an emphasis has been placed on chemoprevention - the use of agents to prevent the development or progression of prostate cancer.
The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene.
Women & Infants Hospital of Rhode Island, a Care New England hospital, announced today that it has been recognized as a 2014 Top Performer on Key Quality Measures by The Joint Commission, the leading accreditor of health care organizations in the U.S.
Dietary cadmium, a toxic metal widely dispersed in the environment and found in many farm fertilizers, may lead to an increased risk of breast cancer, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.
Stage III colon cancer patients in the general population who receive adjuvant treatment for the disease have an improved rate of survival when oxaliplatin is added to 5-fluorouracil (5FU), according to a study published Jan. 20 in the Journal of the National Cancer Institute.
› Verified 6 days ago
Dr. Christian L Hess, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2255 N. 1700 W., #100, Layton, UT 84041 Phone: 801-773-0690 Fax: 801-773-0697 | |
Trent Douglas Richards, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 | |
Dr. Mark L. Hill, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2255 N 1700 W Ste 100, Layton, UT 84041 Phone: 801-773-0690 Fax: 801-773-0697 | |
Dr. Michael D Washburn, M.D., P.C. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2255 N 1700 W, 100, Layton, UT 84041 Phone: 801-773-0690 Fax: 801-773-0697 | |
Laurence M Nelson Jr., MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 | |
Robert L Treft, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1580 W Antelope Dr, Suite 175, Layton, UT 84041 Phone: 801-773-2233 Fax: 801-773-2375 |